Clinical trial
Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic…
NCT00493883 · Southwestern Regional Medical Center, Other · Completed
Key facts
| NCT number | NCT00493883 |
|---|---|
| Title | Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors |
| Official title | Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors |
| Lead sponsor | Southwestern Regional Medical Center, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma, Hepatocellular, Liver Neoplasms |
| Intervention type | Device |
| Interventions | yttrium Y 90 microspheres (TheraSphere®) |
| Enrollment | 81 |
| Start date | Dec 1, 2006 |
| Primary completion | Dec 1, 2011 |
| Completion | Dec 1, 2011 |
| First posted | Jun 28, 2007 |
| Last update posted | May 13, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: